ES2313079T3 - Benzimidazol, benzotiazol, benzoxazol y su utilizacion como moduladores de lta4h. - Google Patents

Benzimidazol, benzotiazol, benzoxazol y su utilizacion como moduladores de lta4h. Download PDF

Info

Publication number: ES2313079T3
Authority: ES; Spain
Prior art keywords: group; benzotiazol; lta4h; benzoxazol; benzimidazol
Prior art date: 2003-07-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

ES04779375T

Other languages

English (en)

Spanish (es)

Inventor

Frank U. Axe

Scott D. Bembenek

Christopher R. Butler

James P. Edwards

Anne M. Fourie

Cheryl A. Grice

Brad M. Savall

Kevin L. Tays

Jianmei Wei

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Janssen Pharmaceutica NV

Original Assignee

Janssen Pharmaceutica NV

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-07-28

Filing date

2004-07-27

Publication date

2009-03-01

2004-07-27 Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV

2009-03-01 Application granted granted Critical

2009-03-01 Publication of ES2313079T3 publication Critical patent/ES2313079T3/es

2024-07-27 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 title 1
HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 title 1
-1 BENZOTIAZOL Chemical compound 0.000 title 1
101000619898 Homo sapiens Leukotriene A-4 hydrolase Proteins 0.000 title 1
102100022118 Leukotriene A-4 hydrolase Human genes 0.000 title 1
229910052760 oxygen Inorganic materials 0.000 abstract 2
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
150000001408 amides Chemical class 0.000 abstract 1
229910052799 carbon Inorganic materials 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
150000002148 esters Chemical class 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
229910052757 nitrogen Inorganic materials 0.000 abstract 1
IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 1
QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1
229910052717 sulfur Inorganic materials 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/622—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/626—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B
- C04B35/63—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B using additives specially adapted for forming the products, e.g.. binder binders
- C04B35/632—Organic additives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pulmonology (AREA)
Manufacturing & Machinery (AREA)
Ceramic Engineering (AREA)
Rheumatology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Biomedical Technology (AREA)
Structural Engineering (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Materials Engineering (AREA)
Inorganic Chemistry (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Dermatology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Immunology (AREA)
Hospice & Palliative Care (AREA)
Epidemiology (AREA)
Plural Heterocyclic Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

ES04779375T 2003-07-28 2004-07-27 Benzimidazol, benzotiazol, benzoxazol y su utilizacion como moduladores de lta4h. Expired - Lifetime ES2313079T3 (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US49071003P	2003-07-28	2003-07-28
US490710P		2003-07-28

Publications (1)

Publication Number	Publication Date
ES2313079T3 true ES2313079T3 (es)	2009-03-01

Family

ID=34115427

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
ES04779219T Expired - Lifetime ES2311858T3 (es)	2003-07-28	2004-07-27	Derivados de benzimidazol, benzotiazol y benzoxazol y su uso como moduladores de lta4h.
ES04779375T Expired - Lifetime ES2313079T3 (es)	2003-07-28	2004-07-27	Benzimidazol, benzotiazol, benzoxazol y su utilizacion como moduladores de lta4h.

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
ES04779219T Expired - Lifetime ES2311858T3 (es)	2003-07-28	2004-07-27	Derivados de benzimidazol, benzotiazol y benzoxazol y su uso como moduladores de lta4h.

Country Status (28)

Country	Link
US (2)	US20050043379A1 (pl)
EP (2)	EP1660492B1 (pl)
JP (2)	JP2007500703A (pl)
KR (2)	KR20060054408A (pl)
CN (2)	CN1856490A (pl)
AR (2)	AR045729A1 (pl)
AT (2)	ATE405562T1 (pl)
AU (2)	AU2004261610B2 (pl)
BR (2)	BRPI0412345A (pl)
CA (2)	CA2534212A1 (pl)
CY (1)	CY1108560T1 (pl)
DE (2)	DE602004015620D1 (pl)
DK (2)	DK1660492T3 (pl)
ES (2)	ES2311858T3 (pl)
HR (2)	HRP20060041B1 (pl)
IL (1)	IL173372A (pl)
MY (1)	MY145080A (pl)
NO (2)	NO20060771L (pl)
NZ (2)	NZ544970A (pl)
PL (2)	PL1660491T3 (pl)
PT (2)	PT1660492E (pl)
RU (2)	RU2373204C2 (pl)
SG (2)	SG129449A1 (pl)
SI (2)	SI1660491T1 (pl)
TW (2)	TWI362383B (pl)
UA (2)	UA82888C2 (pl)
WO (2)	WO2005012297A1 (pl)
ZA (2)	ZA200601716B (pl)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1856490A (zh) *	2003-07-28	2006-11-01	詹森药业有限公司	苯并咪唑、苯并噻唑和苯并噁唑衍生物及其作为lta4h调节剂的应用
US20060223792A1 (en) *	2005-03-31	2006-10-05	Butler Christopher R	Phenyl and pyridyl LTA4H modulators
KR101411167B1 (ko)	2005-04-13	2014-06-23	아스텍스 테라퓨틱스 리미티드	하이드록시벤즈아미드 유도체 및 ｈｓｐ90 억제제로서의이의 용도
EP1717235A3 (en) *	2005-04-29	2007-02-28	Bioprojet	Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3-receptor ligands
ATE497959T1 (de) *	2005-09-02	2011-02-15	Hoffmann La Roche	Benzoxazol-, oxazolopyridin-, benzothiazol- und thiazolopyridinderivate
US20070078263A1 (en)	2005-09-21	2007-04-05	Decode Chemistry, Inc.	Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation
US7750012B2 (en) *	2005-12-21	2010-07-06	Decode Genetics Ehf	Biaryl nitrogen-heterocycle inhibitors of LTA4H for treating inflammation
AU2006327245A1 (en) *	2005-12-21	2007-06-28	Decode Genetics Ehf	Biaryl substituted nitrogen containing heterocycle inhibitors of LTA4H for treating inflammation
CA2634699A1 (en)	2005-12-21	2007-06-28	Decode Genetics Ehf	N-linked aryl heteroaryl inhibitors of lta4h for treating inflammation
WO2007079078A1 (en) *	2005-12-29	2007-07-12	Bayer Schering Pharma Aktiengesellschaft	Diamine derivatives as inhibitors of leukotriene a4 hydrolase
JP2009525269A (ja) *	2006-01-30	2009-07-09	ユーロ−セルティークエス．エイ．	カルシウムチャネルブロッカーとしての環状尿素化合物
US7754725B2 (en)	2006-03-01	2010-07-13	Astex Therapeutics Ltd.	Dihydroxyphenyl isoindolymethanones
US7951829B2 (en) *	2006-05-03	2011-05-31	Janssen Pharmaceutica Nv	Benzimidazole modulators of VR1
AU2007260356B2 (en) *	2006-06-16	2013-01-24	H. Lundbeck A/S	Crystalline forms of 4- [2- (4-methylphenylsulfanyl) -phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain
WO2008019284A1 (en) *	2006-08-04	2008-02-14	Decode Genetics Ehf	Phenoxymethylalkyne inhibitors of lta4h for treating inflammation
US8115005B2 (en)	2006-08-04	2012-02-14	Decode Genetics Ehf.	Pyrazolylphenyl and pyrrolylphenyl inhibitors of LTA4H for treating inflammation
WO2008019306A2 (en) *	2006-08-04	2008-02-14	Decode Genetics Ehf	Aryl amino acid derivatives as inhibitors of lta4h (leukotriene a4 hydrolase) for treating inflammation
EP2073802A1 (en)	2006-10-12	2009-07-01	Astex Therapeutics Limited	Pharmaceutical combinations
JP5518478B2 (ja)	2006-10-12	2014-06-11	アステックス、セラピューティックス、リミテッド	医薬化合物
JP5528807B2 (ja)	2006-10-12	2014-06-25	アステックス、セラピューティックス、リミテッド	複合薬剤
WO2008044041A1 (en)	2006-10-12	2008-04-17	Astex Therapeutics Limited	Pharmaceutical combinations
GB0620259D0 (en)	2006-10-12	2006-11-22	Astex Therapeutics Ltd	Pharmaceutical compounds
TW200906396A (en) *	2007-02-14	2009-02-16	Janssen Pharmaceutica Nv	LTA4H modulators and uses thereof
EP2134704B1 (en) *	2007-03-08	2010-09-22	Irm Llc	Compounds and compositions as modulators of gpr119 activity
JPWO2008120710A1 (ja) *	2007-03-30	2010-07-15	パナソニック電工株式会社	活動強度計
AR069126A1 (es) *	2007-10-31	2009-12-30	Janssen Pharmaceutica Nv	Diaminas en puente o fusionadas sustituidas con arilo como moduladores de leucotrieno a4 hidrolasa
EP2231159A1 (en) *	2007-11-16	2010-09-29	Abbott Laboratories	Method of treating arthritis
SI2336125T1 (sl) *	2008-04-11	2013-04-30	Janssen Pharmaceutica N.V.	Tiazolopiridin-2-iloksi-fenil in tiazolopirazin-2-iloksi-fenil amini kot modulatorji levkotrien a4 hidrolaze
GB0806527D0 (en)	2008-04-11	2008-05-14	Astex Therapeutics Ltd	Pharmaceutical compounds
EP2294066B9 (en)	2008-04-28	2015-03-11	Janssen Pharmaceutica, N.V.	Benzoimidazoles as prolyl hydroxylase inhibitors
CN102459251B (zh) *	2009-05-14	2015-05-20	詹森药业有限公司	作为白三烯a4水解酶的调节剂的具有两个稠合双环杂芳基部分的化合物
CN102442962A (zh) *	2010-11-10	2012-05-09	江苏德峰药业有限公司	1-烷基四氮唑的生产方法
CN102442961A (zh) *	2010-11-10	2012-05-09	江苏德峰药业有限公司	1-甲基四氮唑的生产方法
US9273034B2 (en)	2011-10-25	2016-03-01	Janssen Pharmaceutica Nv	Meglumine salt formulations of 1-(5,6-dichloro-1H-benzo[D]imidazol-2-yl)-1H-pyrazole-4-carboxylic acid
ES2864862T3 (es)	2013-03-12	2021-10-14	Celltaxis Llc	Métodos de inhibición de la leucotrieno A4 hidrolasa
MX2015011677A (es)	2013-03-14	2016-07-08	Celtaxsys Inc	Inhibidores de leucotrieno a4 hidrolasa.
WO2014152536A2 (en)	2013-03-14	2014-09-25	Celtaxsys, Inc.	Inhibitors of leukotriene a4 hydrolase
RU2678196C2 (ru)	2013-03-14	2019-01-24	Селтакссис, Инк.	Производные 2-фениламино-3-цианопиразоло[1,5-а]пиримидина, полезные в качестве ингибитора лейкотриен-a4-гидролазы
ME02896B (me) *	2013-12-17	2018-04-20	Lilly Co Eli	Fenoksietilni derivati prstenastog amina i njihova aktivnost kao modulatora receptora ep4
US10752588B2 (en)	2014-12-19	2020-08-25	The Broad Institute, Inc.	Dopamine D2 receptor ligands
WO2016100940A1 (en)	2014-12-19	2016-06-23	The Broad Institute, Inc.	Dopamine d2 receptor ligands
DK3307734T3 (da)	2015-06-09	2020-01-27	Abbvie Inc	Nukleære receptormodulatorer (ror) til behandling af inflammatoriske og autoimmune sygdomme
MX2019006123A (es)	2016-12-21	2019-08-12	Hoffmann La Roche	Metodo para glicomanipulacion in vitro de anticuerpos.
EP3559250A1 (en)	2016-12-21	2019-10-30	H. Hoffnabb-La Roche Ag	Re-use of enzymes in in vitro glycoengineering of antibodies
CN107663192B (zh) *	2017-11-03	2019-05-10	梯尔希（南京）药物研发有限公司	一种雷贝拉唑杂质的制备方法
EP3801559B1 (en)	2018-05-31	2025-01-01	Celltaxis, LLC	Method of reducing pulmonary exacerbations in respiratory disease patients
US20210393621A1 (en)	2018-10-26	2021-12-23	The Research Foundation For The State University Of New York	Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia
EP3908278A4 (en) *	2019-01-11	2022-09-28	Naegis Pharmaceuticals Inc.	INHIBITORS OF LEUKOTRIEN SYNTHESIS
CN110026557B (zh) *	2019-05-28	2021-08-27	南方科技大学	一种混合固体颗粒重熔的直写装置及成型方法
KR20230123954A (ko) *	2020-11-19	2023-08-24	텔로 테라퓨틱스, 인코포레이티드	소분자 화합물 및 조성물
US11932630B2 (en) *	2021-04-16	2024-03-19	Novartis Ag	Heteroaryl aminopropanol derivatives
CN113683491A (zh) *	2021-09-01	2021-11-23	王传良	一种4-(2-溴乙基)苯酚的制备方法
CN113735798B (zh) *	2021-09-27	2022-07-12	安徽美致诚药业有限公司	一种盐酸罗沙替丁醋酸酯的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4873346A (en) *	1985-09-20	1989-10-10	The Upjohn Company	Substituted benzothiazoles, benzimidazoles, and benzoxazoles
CA1319144C (en) *	1986-11-14	1993-06-15	Quirico Branca	Tetrahydronaphthalene derivatives
IL90337A0 (en) *	1988-05-24	1989-12-15	Pfizer	Aromatic and heterocyclic carboxamide derivatives as antineoplastic agents
IT1240598B (it) *	1990-03-13	1993-12-17	Mini Ricerca Scient Tecnolog	Derivati amminici ad azione antifungina
US5585492A (en) *	1994-10-11	1996-12-17	G. D. Searle & Co.	LTA4 Hydrolase inhibitors
US5889006A (en) *	1995-02-23	1999-03-30	Schering Corporation	Muscarinic antagonists
IL117149A0 (en) *	1995-02-23	1996-06-18	Schering Corp	Muscarinic antagonists
US5925654A (en) *	1997-03-12	1999-07-20	G.D. Searle & Co.	LTA4 , hydrolase inhibitors
EP1062216A1 (en) *	1998-02-25	2000-12-27	Genetics Institute, Inc.	Inhibitors of phospholipase a2
US6514964B1 (en) *	1999-09-27	2003-02-04	Amgen Inc.	Fused cycloheptane and fused azacycloheptane compounds and their methods of use
US20040110757A1 (en) *	2002-03-21	2004-06-10	Thomas Arrhenius	Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis
CN1856490A (zh) *	2003-07-28	2006-11-01	詹森药业有限公司	苯并咪唑、苯并噻唑和苯并噁唑衍生物及其作为lta4h调节剂的应用
US7541466B2 (en) *	2003-12-23	2009-06-02	Genzyme Corporation	Tetrahydroisoquinoline derivatives for treating protein trafficking diseases
ES2570332T3 (es) *	2005-03-16	2016-05-17	Meda Pharma Gmbh & Co Kg	La combinación de anticolinérgicos y antagonistas del receptor de leucotrieno para el tratamiento de enfermedades respiratorias
TW200906396A (en) *	2007-02-14	2009-02-16	Janssen Pharmaceutica Nv	LTA4H modulators and uses thereof

2004
- 2004-07-27 CN CNA2004800279067A patent/CN1856490A/zh active Pending
- 2004-07-27 AU AU2004261610A patent/AU2004261610B2/en not_active Ceased
- 2004-07-27 DK DK04779375T patent/DK1660492T3/da active
- 2004-07-27 DE DE602004015620T patent/DE602004015620D1/de not_active Expired - Lifetime
- 2004-07-27 SG SG200700691A patent/SG129449A1/en unknown
- 2004-07-27 DE DE602004016002T patent/DE602004016002D1/de not_active Expired - Lifetime
- 2004-07-27 SG SG200700817-0A patent/SG130192A1/en unknown
- 2004-07-27 EP EP04779375A patent/EP1660492B1/en not_active Expired - Lifetime
- 2004-07-27 ES ES04779219T patent/ES2311858T3/es not_active Expired - Lifetime
- 2004-07-27 RU RU2006102510/04A patent/RU2373204C2/ru not_active IP Right Cessation
- 2004-07-27 CA CA002534212A patent/CA2534212A1/en not_active Abandoned
- 2004-07-27 KR KR1020067002211A patent/KR20060054408A/ko not_active Ceased
- 2004-07-27 CN CN200480028138A patent/CN100591679C/zh not_active Expired - Fee Related
- 2004-07-27 ES ES04779375T patent/ES2313079T3/es not_active Expired - Lifetime
- 2004-07-27 US US10/900,152 patent/US20050043379A1/en not_active Abandoned
- 2004-07-27 SI SI200430904T patent/SI1660491T1/sl unknown
- 2004-07-27 UA UAA200601432A patent/UA82888C2/uk unknown
- 2004-07-27 EP EP04779219A patent/EP1660491B1/en not_active Expired - Lifetime
- 2004-07-27 BR BRPI0412345-0A patent/BRPI0412345A/pt not_active IP Right Cessation
- 2004-07-27 JP JP2006521973A patent/JP2007500703A/ja active Pending
- 2004-07-27 AU AU2004261628A patent/AU2004261628B2/en not_active Ceased
- 2004-07-27 DK DK04779219T patent/DK1660491T3/da active
- 2004-07-27 PL PL04779219T patent/PL1660491T3/pl unknown
- 2004-07-27 US US10/900,103 patent/US20050043378A1/en not_active Abandoned
- 2004-07-27 NZ NZ544970A patent/NZ544970A/en unknown
- 2004-07-27 AT AT04779375T patent/ATE405562T1/de active
- 2004-07-27 KR KR1020067002194A patent/KR101149379B1/ko not_active Expired - Fee Related
- 2004-07-27 SI SI200430927T patent/SI1660492T1/sl unknown
- 2004-07-27 PT PT04779375T patent/PT1660492E/pt unknown
- 2004-07-27 JP JP2006522022A patent/JP4726238B2/ja not_active Expired - Fee Related
- 2004-07-27 BR BRPI0413072-3A patent/BRPI0413072A/pt not_active IP Right Cessation
- 2004-07-27 HR HRP20060041AA patent/HRP20060041B1/hr not_active IP Right Cessation
- 2004-07-27 PT PT04779219T patent/PT1660491E/pt unknown
- 2004-07-27 WO PCT/US2004/024309 patent/WO2005012297A1/en not_active Ceased
- 2004-07-27 NZ NZ544938A patent/NZ544938A/en unknown
- 2004-07-27 PL PL04779375T patent/PL1660492T3/pl unknown
- 2004-07-27 WO PCT/US2004/024050 patent/WO2005012296A1/en not_active Ceased
- 2004-07-27 RU RU2006102508/04A patent/RU2359970C2/ru not_active IP Right Cessation
- 2004-07-27 CA CA002534228A patent/CA2534228A1/en not_active Abandoned
- 2004-07-27 UA UAA200601433A patent/UA87986C2/uk unknown
- 2004-07-27 HR HR20060039A patent/HRP20060039A2/xx not_active Application Discontinuation
- 2004-07-27 AT AT04779219T patent/ATE403654T1/de not_active IP Right Cessation
- 2004-07-28 TW TW093122570A patent/TWI362383B/zh not_active IP Right Cessation
- 2004-07-28 MY MYPI20043045A patent/MY145080A/en unknown
- 2004-07-28 AR ARP040102682A patent/AR045729A1/es unknown
- 2004-07-28 TW TW093122566A patent/TW200520756A/zh unknown
- 2004-07-28 AR ARP040102683A patent/AR045730A1/es not_active Application Discontinuation
2006
- 2006-01-26 IL IL173372A patent/IL173372A/en not_active IP Right Cessation
- 2006-02-17 NO NO20060771A patent/NO20060771L/no not_active Application Discontinuation
- 2006-02-20 NO NO20060823A patent/NO20060823L/no not_active Application Discontinuation
- 2006-02-27 ZA ZA200601716A patent/ZA200601716B/en unknown
- 2006-02-27 ZA ZA200601720A patent/ZA200601720B/en unknown
2008
- 2008-10-27 CY CY20081101220T patent/CY1108560T1/el unknown

Also Published As

Publication number	Publication date
RU2006102510A (ru)	2006-07-27
ATE403654T1 (de)	2008-08-15
KR101149379B1 (ko)	2012-06-28
CN100591679C (zh)	2010-02-24
SG130192A1 (en)	2007-03-20
WO2005012297A9 (en)	2007-01-04
EP1660492A1 (en)	2006-05-31
WO2005012296A1 (en)	2005-02-10
BRPI0413072A (pt)	2006-10-03
AU2004261628A1 (en)	2005-02-10
CN1860117A (zh)	2006-11-08
EP1660491A1 (en)	2006-05-31
PT1660491E (pt)	2008-10-10
ZA200601716B (en)	2007-05-30
RU2359970C2 (ru)	2009-06-27
EP1660492B1 (en)	2008-08-20
MY145080A (en)	2011-12-15
UA82888C2 (en)	2008-05-26
DK1660492T3 (da)	2008-11-03
IL173372A (en)	2010-11-30
KR20060057593A (ko)	2006-05-26
IL173372A0 (en)	2006-06-11
DK1660491T3 (da)	2008-11-10
DE602004016002D1 (de)	2008-10-02
US20050043379A1 (en)	2005-02-24
JP2007500706A (ja)	2007-01-18
SI1660492T1 (sl)	2009-02-28
NO20060823L (no)	2006-03-15
HRP20060041B1 (hr)	2014-06-06
US20050043378A1 (en)	2005-02-24
ATE405562T1 (de)	2008-09-15
EP1660491B1 (en)	2008-08-06
AU2004261628B2 (en)	2011-05-12
BRPI0412345A (pt)	2006-10-03
CA2534228A1 (en)	2005-02-10
PL1660492T3 (pl)	2009-01-30
NZ544938A (en)	2009-05-31
SG129449A1 (en)	2007-02-26
CN1856490A (zh)	2006-11-01
DE602004015620D1 (de)	2008-09-18
AR045730A1 (es)	2005-11-09
JP2007500703A (ja)	2007-01-18
AU2004261610B2 (en)	2010-05-20
JP4726238B2 (ja)	2011-07-20
KR20060054408A (ko)	2006-05-22
TW200523255A (en)	2005-07-16
HK1092790A1 (en)	2007-02-16
ES2311858T3 (es)	2009-02-16
AR045729A1 (es)	2005-11-09
CA2534212A1 (en)	2005-02-10
ZA200601720B (en)	2007-11-28
UA87986C2 (uk)	2009-09-10
HRP20060041A2 (en)	2006-11-30
HK1090359A1 (en)	2006-12-22
TW200520756A (en)	2005-07-01
TWI362383B (en)	2012-04-21
CY1108560T1 (el)	2014-04-09
WO2005012297A1 (en)	2005-02-10
RU2006102508A (ru)	2006-07-27
NO20060771L (no)	2006-04-21
NZ544970A (en)	2009-02-28
HRP20060039A2 (en)	2006-08-31
RU2373204C2 (ru)	2009-11-20
AU2004261610A1 (en)	2005-02-10
PT1660492E (pt)	2008-11-13
SI1660491T1 (sl)	2009-02-28
PL1660491T3 (pl)	2009-01-30

Publication	Publication Date	Title
ES2313079T3 (es)	2009-03-01	Benzimidazol, benzotiazol, benzoxazol y su utilizacion como moduladores de lta4h.
PE20130375A1 (es)	2013-04-10	Compuestos de triazolopiridinas y triazolopirazinas inhibidores de c-met y composiciones de los mismos
PE20070218A1 (es)	2007-03-15	COMPUESTOS DE CICLOALQUILO AMINO-HIDANTOINA Y USO DE ESTOS PARA LA MODULACION DE ß-SECRETASA
AR047076A1 (es)	2006-01-04	Compuestos de pirrolotriazina como inhibidores de tirosina quinasas, composiciones farmaceuticas
PE20020707A1 (es)	2002-08-11	Compuestos tripeptidicos como inhibidores de la proteasa ns3 del virus de hepatitis c
TW200510441A (en)	2005-03-16	Novel compounds
PE20121010A1 (es)	2012-08-06	Derivados de bencimidazol
DE602004016127D1 (de)	2008-10-09	Antagonisten der opioidrezeptoren
TNSN08414A1 (en)	2010-04-14	Terphenyl derivatives for treatment of alzheimer's disease
CO5611139A2 (es)	2006-02-28	Pirimidinas aril sustituidas y el uso de las mismas
PE20091842A1 (es)	2009-12-04	Pirrolidinonas como activadores de glucoquinasa
AR046297A1 (es)	2005-11-30	Inhibidores de la dpp - iv metodos para prepararlos y composiciones farmaceuticas que los contienen como agente activo
UY29016A1 (es)	2006-02-24	Analogos de dipeptidos inhibidores de la hepatitis c
IL187208A0 (en)	2008-02-09	Antagonists of the vanilloid receptor subtype 1 (vr1) and uses thereof
PE20080889A1 (es)	2008-06-27	Aminometil-4-imidazoles
TW200719886A (en)	2007-06-01	Dihydrobenzofuran derivatives and uses thereof
CR8505A (es)	2008-09-09	Derivados de (3-oxo-3,4-dihidroquinoxalin-2-il-amino)-benzamida y compuesto relacionado, como inhibidores de glucogeno fosforilasa para el tratamiento de la diabetes y obesidad
DE60236719D1 (de)	2010-07-29	Purinderivate als antagonisten an purinergen rezeptoren
JOP20190239A1 (ar)	2019-10-09	مركبات مثبطة لـ vmat2 وتركيبات منها
PE20061295A1 (es)	2006-12-24	Derivados de acetileno
PE20061490A1 (es)	2007-02-09	Derivados de ciclohexanosulfonilo como inhibidores del transportador de glicina glyt1
EA201000881A1 (ru)	2010-12-30	Пиридилметил-сульфонамидные соединения
AR060379A1 (es)	2008-06-11	Compuesto y composicion herbicida
EA200501148A1 (ru)	2006-04-28	Пиридилоксиметильные и бензизоксазольные азабициклические производные
PE20061156A1 (es)	2006-12-16	Derivados de benzamida como agentes inhibidores del transportador de glicina